Le Lézard
Classified in: Health
Subjects: MAV, POL, MAT

Media Advisory - Sherwin Edwards from Vap Select to Participate in Sixth Estate Panel


ST. JANVIER, QC, Jan. 18, 2018 /CNW Telbec/ - Sherwin Edwards, Founder, President and CEO of Vap Select will join a cross section of experts who will discuss the merits of vaping as an alternative to cigarette smoke, to understand if vaping is really an option as a harm-reduction and life-saving alternative to tobacco products. The panel is organized by the Sixth Estate and will be moderated by Susan Delacourt.

Event: If Quitting Is Not An Option ... Is Vaping?
Information: https://sixthestate.ca/events/if-quitting-is-not-an-option-is-vaping/ 
When: January 23, 2018 
Where: Ottawa Marriott Hotel, 100 Kent Street
Program begins at 12:00 p.m. and finishes at 1:00 p.m.

Sherwin has taken a stand against the federal government's Bill S-5: An Act to amend the Tobacco Act and the Non-smokers' Health Act and to make consequential amendments to other Acts. His position is that Bill S-5 should not include vaping products by classifying them on the same shelf as tobacco products. He sponsored E-1237, an online e-petition, which calls for the suspension of Bill S-5 and for a distinction between tobacco and vaping products. The petition gathered 10,251 signatures while it remained online until the December 23, 2017 closing, making it one of the most successful online petitions submitted to the Canadian Parliament. Only 500 signatures are required for a petition to be read in the House of Commons. The petition gathered signatures from across Canada.

Sherwin is available for media interviews following the Sixth Estate panel discussion.

 

SOURCE Vap Select


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: